Dalazatide (TFA)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-P3507A-1MG | 1 mg | 710,00 | Add | |
| HY-P3507A-5MG | 5 mg | 1'914,00 | Add | |
| HY-P3507A-10MG | 10 mg | 2'484,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
Dalazatide (ShK-186) TFA is a specific Kv1.3 potassium channel peptide inhibitor. Dalazatide TFA can be used in the study of autoimmune diseases such as multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes and inflammatory bowel disease[1][2][3].
| Category | Peptide |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, Inflammation/Immunology, Membrane Transporter/Ion Channel |
| Format | Solubility: H2O : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: Phase 1 |
| Purity | 99.17% |
| Molecular Formula | C184H296N57O55PS7.xC2HF3O2 |
| Molecular Weight | 4442.08 |
| Storage Conditions | -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Blue Ice |
| Material Safety Data Sheet | Download PDF |
